Indraprastha Medical Corporation Limited provides hospital services in India. It offers services primarily in the areas of anesthesiology, advanced pediatrics, bone marrow transplant, cosmetic and plastic surgery, dental clinic, dermatology, elder care department, neonatology, general and advance laparoscopic surgery, pediatric urology and pediatric surgery, endocrinology, ear, nose, throat, fetal medicine, gastroenterology and GI surgery, gynecology and obstetrics, heart institutes, infertility care, critical care, bariatric, cancer, emergency, nephrology, neurosciences, orthopedics, robotic surgery, spine, transplant, internal medicine, nuclear medicine, ophthalmology, psychiatry and clinical psychology, radiology/radio diagnosis, rheumatology, urology and andrology, and vascular and endovascular surgery. The company also operates cosmetic and pain clinic, and wellness center, as well as Apollo 24/7 app; and offers services in the areas of sugar, dietetics and clinical nutrition, hyperbaric oxygen therapy, laboratory services, physiotherapy and rehabilitation, and transfusion medicine. Indraprastha Medical Corporation Limited was incorporated in 1988 and is based in New Delhi, India. The ISIN of this stock is INE681B01017.